Vimarsana
Biggest News Aggregation in the World

Regulatory Activity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulatory Activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulatory Activity Today - Breaking & Trending Today

FiscalNote Announces Expansion of Global Policy and Analysis Coverage to Include China - Vimarsana News

FiscalNote Announces Expansion of Global Policy and Analysis Coverage to Include China

WASHINGTON, November 06, 2023--FISCALNOTE ANNOUNCES EXPANSION OF GLOBAL POLICY & ANALYSIS COVERAGE TO INCLUDE CHINA - Covers National, Provincial Legislative and Regulatory Policy

Source: yahoo.com
Therapeutic Proteins Market Size Expected To Reach 200 Billion By 2027 - Vimarsana News

Therapeutic Proteins Market Size Expected To Reach 200 Billion By 2027

The Business Research Company’s Therapeutic Proteins Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032

NY Medicaid Inspector General Finalizes Rulemaking for Medicaid Program Fraud, Waste and Abuse Prevention | Harris Beach PLLC - Vimarsana News

NY Medicaid Inspector General Finalizes Rulemaking for Medicaid Program Fraud, Waste and Abuse Prevention | Harris Beach PLLC

On December 28, 2022, New York State Register published a summary of the New York State Office of the Medicaid Inspector General’s (“OMIG”) Notice of Adoption for Rulemaking on Medicaid...

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem in China to Treat Antimicrobial Resistant Infections - Vimarsana News

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem in China to Treat Antimicrobial Resistant Infections

Vaborem, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in China The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and marketing this asset, and SciClone's development and commercial presence in China Menarini will receive a total payment of up to 115 million, which includes milestone payments and tiered royalty on net sales, during the term SINGAPORE, Sept. 20, 2022 /PRNewswire/ -- A. Menarini Asia-Pacific Holdings Pte....

LexisNexis Risk Solutions Sanctions Pulse Special Edition: An Analysis of Recent Sanctions Activity - Vimarsana News

LexisNexis Risk Solutions Sanctions Pulse Special Edition: An Analysis of Recent Sanctions Activity

/PRNewswire/ -- LexisNexis® Risk Solutions released the findings from a special edition of its Sanctions Pulse infographic focused on the sanctions that have...